Human granulocytic anaplasmosis

Last updated
Human granulocytic anaplasmosis
Other namesHuman granulocytic ehrlichiosis (HGE) [1] [2]
Anaplasma phagocytophilum cultured in human promyelocytic cell line HL-60.jpg
Anaplasma phagocytophilum cultured in a human promyelocytic cell line, arrows point to cells containing prominent bacterial morulae
Specialty Infectious diseases   OOjs UI icon edit-ltr-progressive.svg

Human granulocytic anaplasmosis (HGA) is a tick-borne, infectious disease caused by Anaplasma phagocytophilum , an obligate intracellular bacterium that is typically transmitted to humans by ticks of the Ixodes ricinus species complex, including Ixodes scapularis and Ixodes pacificus in North America. These ticks also transmit Lyme disease and other tick-borne diseases. [3]

Contents

The bacteria infect white blood cells called neutrophils, causing changes in gene expression that prolong the life of these otherwise short-lived cells. [4]

Signs and symptoms

Signs and symptoms may include: [5] [6] [7]

Symptoms may be minor, as evidenced by surveillance studies in high-risk areas. Gastrointestinal tract symptoms occur in less than half of patients and a skin rash is seen in less than 10% of patients. [5] It is also characterized by a low number of platelets, a low number of white blood cells, and elevated serum transaminase levels in the majority of infected patients. [5] Even though people of any age can get HGA, it is usually more severe in the aging or immune-compromised. Some severe complications may include respiratory failure, kidney failure, and secondary infections. [5] [7]

Cause

A. phagocytophilum is transmitted to humans by Ixodes ticks. These ticks are found in the US, Europe, and Asia. In the US, I. scapularis is the tick vector in the East and Midwest states, and I. pacificus in the Pacific Northwest. [8] In Europe, the I. ricinus is the main tick vector, and I. persulcatus is the currently known tick vector in Asia. [9]

The major mammalian reservoir for A. phagocytophilum in the eastern United States is the white-footed mouse, Peromyscus leucopus . Although white-tailed deer and other small mammals harbor A. phagocytophilum, evidence suggests that they are not a reservoir for the strains that cause HGA. [10] [11] A tick that has a blood meal from an infected reservoir becomes infected themselves. If an infected tick then latches onto a human the disease is then transmitted to the human host and A.phagocytophilum symptoms can arise. [12]

Anaplasma phagocytophilum shares its tick vector with other human pathogens, and about 10% of patients with HGA show serologic evidence of coinfection with Lyme disease, babesiosis, or tick-borne meningoencephalitis. [12]

While it is rare, it is possible for HGA to be transmitted human-to-human via a blood transfusion, in which case it is called Transfusion-Transmitted Anaplasmosis (TTA). [13]

Major surface proteins

Many major surface proteins (MSPs) are found in Anaplasma and those which interact with Anaplasma can mainly be found in A. marginale and A. phagocytophilum. [14] There are many different phenotypic traits that are associated with MSPs, because each MSP can only infect certain animals in certain conditions. [14] A. phagocytophilum infects the most vast array of living things, including humans, and all around the world. [14] A. marginale evolved to be more specific in infecting animals, such as deer and cattle in the subtropics and tropics. [14] The main difference between these two MSPs is that the host cell for A. phagocytophilum is the granulocyte, while the host cell for A. marginale is erythrocytes. [14] It is likely that these MSPs coevolved, because they had previously interacted via tick-pathogen interaction. [14]

Anaplasma MSPs can not only cooperate with vertebrates, but also invertebrates, which make these phenotypes evolve faster than others, because they have a lot of selective forces acting on them. [14]

Diagnosis

Clinically, HGA is essentially indistinguishable from human monocytic ehrlichiosis, the infection caused by Ehrlichia chaffeensis , and other tick-borne illnesses such as Lyme disease may be suspected. [15] As Ehrlichia serologies can be negative in the acute period, PCR is very useful for diagnosis. [16]

Prevention

Currently, there is no vaccine against human granulocytic anaplasmosis, so antibiotics are the only form of treatment. [9] The best way to prevent HGA is to prevent getting tick bites. [17]

Treatment

Doxycycline is the treatment of choice. If anaplasmosis is suspected, treatment should not be delayed while waiting for a definitive laboratory confirmation, as prompt doxycycline therapy has been shown to improve outcomes. [15] Presentation during early pregnancy can complicate treatment. Doxycycline compromises dental enamel during development. [18] Although rifampin is indicated for post-delivery pediatric and some doxycycline-allergic patients, it is teratogenic. Rifampin is contraindicated during conception and pregnancy. [19]

If the disease is not treated quickly, sometimes before the diagnosis, the person has a high chance of mortality. [9] Most people make a complete recovery, though some people are intensively cared for after treatment. [9] A reason for a person needing intensive care is if the person goes too long without seeing a doctor or being diagnosed. [9] The majority of people, though, make a complete recovery with no residual damage. [9]

Epidemiology

From the first reported case in 1994 until 2021, HGA's rates of incidence have regularly increased in the United States. [20] Increases in reported cases of Lyme disease, primarily caused by the pathogen Borrelia burgdorferi , and babesiosis have also been observed over the same period, which share a tick vector. [20] [ additional citation(s) needed ] Before 2000, there were less than 300 HGA cases reported per year. In 2000, there were only 350 reported cases. [20] From 2009-2010, HGA experienced a 52% increase in the number of cases reported. [20] Annual cases of anaplasmosis reported to the U.S. Centers for Disease Control and Prevention reached a record high of 6,729 in 2021, having steadily increased during the previous decade. [20]

In Europe, the number of annual reported cases is lower, below 300, but seroprevalence (for antibody markers of infection) averages 8.3%, suggesting that undiagnosed, unreported or subclinical infections regularly occur. [21] Anaplasmosis also is reported in South Korea, Japan and China; the case fatality rate in one study performed in China between 2009 and 2010 was reported to be 8.1%, [22] but this may be attributable to underdiagnosis. [23] Outbreaks in China previously ascribed to anaplasmosis have been re-evaluated due to the discovery of severe fever with thrombocytopenia syndrome virus, reported in 2011, [24] whose infection clinically mimics anaplasmosis and may co-occur, but unlike anaplasmosis is associated with hemorrhagic fever. [21] [25]

History

The first outbreak of Human Granulocytic Anaplasmosis (HGA) in the United States began with a patient in early 1990 in Wisconsin. He was kept in the hospital in Minnesota for testing, but died without a diagnosis. [9] Over the next couple of years, many people within the same area of Wisconsin and Minnesota had come down with the same symptoms. [9] It was discovered in 1994 that it was Human Granulocytic Ehrlichiosis (HGE), later to be known as HGA. [12]

Terminology

Although the infectious agent is known to be from the Anaplasma genus, the term "human granulocytic ehrlichiosis" (HGE) has been previously used, reflecting the prior classification of the organism. E. phagocytophilum and E. equi were reclassified as Anaplasma phagocytophilum. [26] [27]

See also

References

  1. Malik A, Jameel M, Ali S, Mir S (2005). "Human granulocytic anaplasmosis affecting the myocardium". J Gen Intern Med. 20 (10): C8–10. doi:10.1111/j.1525-1497.2005.00218.x. PMC   1490240 . PMID   16191146.
  2. "Human Anaplasmosis Basics - Minnesota Dept. of Health". Archived from the original on 2018-03-14. Retrieved 2009-04-13.
  3. Holden, K.; Boothby, J. T.; Anand, S.; Massung, R. F. (2003). "Browse BioOne Complete". Journal of Medical Entomology. 40 (4): 534–9. doi: 10.1603/0022-2585-40.4.534 . ISSN   0022-2585. PMID   14680123.
  4. Lee HC, Kioi M, Han J, Puri RK, Goodman JL (September 2008). "Anaplasma phagocytophilum-induced gene expression in both human neutrophils and HL-60 cells". Genomics. 92 (3): 144–51. doi:10.1016/j.ygeno.2008.05.005. PMID   18603403.
  5. 1 2 3 4 Murray, Patrick R.; Rosenthal, Ken S.; Pfaller, Michael A. (2021). "4. Microscopy and in Vitro Culture". Medical microbiology (9th ed.). Elsevier. pp. 18–23, See p.21. ISBN   978-0-323-67450-8. OCLC   1144922746.
    Murray; Rosenthal; Pfaller (2021). 34. Rickettsia, Ehrlichia, and Related Bacteria. pp. 343–352.
  6. MacQueen D, Centellas F (September 2022). "Human Granulocytic Anaplasmosis". Infect Dis Clin North Am. 36 (3): 639–654. doi:10.1016/j.idc.2022.02.008. PMID   36116840.
  7. 1 2 Dumic I, Jevtic D, Veselinovic M, Nordstrom CW, Jovanovic M, Mogulla V, Veselinovic EM, Hudson A, Simeunovic G, Petcu E, Ramanan P (July 2022). "Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases". Microorganisms. 10 (7): 10071433. doi: 10.3390/microorganisms10071433 . PMC   9318722 . PMID   35889152.
  8. Dumler JS, Madigan JE, Pusterla N, Bakken JS (July 2007). "Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment". Clinical Infectious Diseases. 45 (Suppl 1): S45–51. doi:10.1086/518146. PMID   17582569. S2CID   25167899.
  9. 1 2 3 4 5 6 7 8 Bakken, Johan S.; Dumler, J. Stephen (2006-10-01). "Clinical Diagnosis and Treatment of Human Granulocytotropic Anaplasmosis". Annals of the New York Academy of Sciences. 1078 (1): 236–247. Bibcode:2006NYASA1078..236B. doi:10.1196/annals.1374.042. ISSN   1749-6632. PMID   17114714. S2CID   33910710.
  10. Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Ohl CA (March 2006). "Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a practical guide for physicians and other health-care and public health professionals". MMWR Recomm Rep. 55 (RR-4): 1–27. PMID   16572105.
  11. Massung RF, Courtney JW, Hiratzka SL, Pitzer VE, Smith G, Dryden RL (October 2005). "Anaplasma phagocytophilum in white-tailed deer". Emerging Infectious Diseases. 11 (10): 1604–6. doi:10.3201/eid1110.041329. PMC   3366735 . PMID   16318705.
  12. 1 2 3 Dumler JS, Choi KS, Garcia-Garcia JC, et al. (December 2005). "Human granulocytic anaplasmosis and Anaplasma phagocytophilum". Emerging Infectious Diseases. 11 (12): 1828–34. doi:10.3201/eid1112.050898. PMC   3367650 . PMID   16485466.
  13. Goel, Ruchika; Westblade, Lars F.; Kessler, Debra A.; Sfeir, Maroun; Slavinski, Sally; Backenson, Bryon; et al. (August 2018). "Death from transfusion-transmitted anaplasmosis". Emerging Infectious Diseases . 24 (8): 1548–50. doi:10.3201/eid2408.172048. PMC   6056119 . PMID   30016241.
  14. 1 2 3 4 5 6 7 de la Fuente, José; Kocan, Katherine M.; Blouin, Edmour F.; Zivkovic, Zorica; Naranjo, Victoria; Almazán, Consuelo; Esteves, Eliane; Jongejan, Frans; Daffre, Sirlei (2010-02-10). "Functional genomics and evolution of tick–Anaplasma interactions and vaccine development". Veterinary Parasitology. Ticks and Tick-borne Pathogens. 167 (2–4): 175–186. doi:10.1016/j.vetpar.2009.09.019. hdl: 10261/144221 . PMID   19819630.
  15. 1 2 Hamburg BJ, Storch GA, Micek ST, Kollef MH (March 2008). "The importance of early treatment with doxycycline in human ehrlichiosis". Medicine. 87 (2): 53–60. doi: 10.1097/MD.0b013e318168da1d . PMID   18344803. S2CID   2632346.
  16. Prince LK, Shah AA, Martinez LJ, Moran KA (August 2007). "Ehrlichiosis: making the diagnosis in the acute setting". Southern Medical Journal. 100 (8): 825–8. doi:10.1097/smj.0b013e31804aa1ad. PMID   17713310. S2CID   31487400.
  17. Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc (2006-11-01). "The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America". Clinical Infectious Diseases. 43 (9): 1089–1134. doi: 10.1086/508667 . ISSN   1058-4838. PMID   17029130.
  18. Muffly T, McCormick TC, Cook C, Wall J (2008). "Human granulocytic ehrlichiosis complicating early pregnancy". Infect Dis Obstet Gynecol. 2008: 1–3. doi: 10.1155/2008/359172 . PMC   2396214 . PMID   18509484.
  19. Krause PJ, Corrow CL, Bakken JS (September 2003). "Successful treatment of human granulocytic ehrlichiosis in children using rifampin". Pediatrics. 112 (3 Pt 1): e252–3. doi:10.1542/peds.112.3.e252. PMID   12949322.
  20. 1 2 3 4 5 "Statistics | Anaplasmosis | CDC". www.cdc.gov. 2025-03-05. Retrieved 2025-03-10.
  21. 1 2 Matei, I.A.; Estrada-Peña, A.; Cutler, S.J.; Vayssier-Taussat, M.; Varela-Castro, L.; Potkonjak, A.; Zeller, H.; Mihalca, A.D. (2019). "A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe". Parasites & Vectors. 12. doi: 10.1186/s13071-019-3852-6 . PMC   6925858 . PMID   31864403. Art. No. 599.
  22. Zhang, L.; Wang, G.; Liu, Q.; Chen, C.; Li, J.; Long, B.; Yu, H.; Zhang, Z.; He, J.; Qu, Z.; Yu, J.; Liu, Y.; Dong, T.; Yao, N.; Wang, Y.; Cheng, X.; Xu, J. (2013). "Molecular analysis of Anaplasma phagocytophilum isolated from patients with febrile diseases of unknown etiology in China". PLoS One. 8 (2). doi: 10.1371/journal.pone.0057155 . PMC   3579781 . PMID   23451170. Art. No. e57155.
  23. Wang, F.; Yan, M.; Liu, A.; Chen, T.; Luo, L.; Li, L.; Teng, Z.; Li, B.; Ji, Z.; Jian, M.; Ding, Z.; Wen, S.; Zhang, Y.; Yue, P.; Cao, W.; Xu, X.; Zhou, G.; Bao, F. (2020). "The seroprevalence of Anaplasma phagocytophilum in global human populations: A systematic review and meta-analysis". Transboundary and Emerging Diseases. 67 (5): 2050–2064. doi:10.1111/tbed.13548. PMID   32180352.
  24. Yu, X.-J.; Liang, M.-F.; Zhang, S.-Y.; Liu, Y.; Li, J.-D.; Sun, Y.-L.; Zhang, L.; Zhang, Q.-F.; Popov, V.L.; Li, C.; Qu, J.; Li, Q.; Zhang, Y.-P.; et al. (2011). "Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China". New England Journal of Medicine. 364 (16): 1523–1532. doi: 10.1056/NEJMoa1010095 . PMC   3113718 . PMID   21410387.
  25. Liu, Y.; Li, Q.; Hu, W.; Wu, J.; Wang, Y.; Mei, L.; Walker, D.H.; Ren, J.; Wang, Y.; Yu, X.-J. (2012). "Person-to-Person Transmission of Severe Fever with Thrombocytopenia Syndrome Virus". Vector-Borne and Zoonotic Diseases. 12 (2): 156–160. doi:10.1089/vbz.2011.0758. PMID   21955213.
  26. Saleem S, Ijaz M, Farooqi SH, Ghaffar A, Ali A, Iqbal K, Mehmood K, Zhang H (June 2018). "Equine Granulocytic Anaplasmosis 28 years later". Microb Pathog. 119: 1–8. doi:10.1016/j.micpath.2018.04.001. PMID   29626656.
  27. Ismail N, Bloch KC, McBride JW (March 2010). "Human ehrlichiosis and anaplasmosis". Clin Lab Med. 30 (1): 261–92. doi:10.1016/j.cll.2009.10.004. PMC   2882064 . PMID   20513551.

>